Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Gains 6%; BSE HEALTHCARE Index Up 1.9%
Tue, 8 Oct 17:0

KRSNAA DIAGNOSTICS Gains 6%; BSE HEALTHCARE Index Up 1.9%Image source: peterschreiber.media/www.istockphoto.com

KRSNAA DIAGNOSTICS share price has zoomed 6% and is presently trading at Rs 826.5.

Meanwhile, the BSE HEALTHCARE index is at 43,953.5 (up 1.9%).

Among the top gainers in the BSE HEALTHCARE index today are Jubilant Pharmova (up 6.5%) and GSK Pharma (up 4.4%).

ASTRAZENECA PHARMA (down 1.0%) and Pfizer (down 0.4%) are among the top losers today.

Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 678.4 to Rs 826.5, registering a gain of Rs 148.2 (up 21.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,012.1 to 43,953.5, registering a gain of 56.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 166.6%), Glenmark Pharma (up 114.8%) and SUVEN PHARMACEUTICALS (up 109.7%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,634.8 (up 0.7%).

The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 4.8%) and M&M (up 3.4%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 25,013.2 . TATA STEEL 2% CCPS and Dr Reddy NCD1 are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,226.0 to 81,634.8, registering a gain of 16,408.8 points (up 25.2%).

KRSNAA DIAGNOSTICS Financial Update...

KRSNAA DIAGNOSTICS net profit grew 22.4% YoY to Rs 179 million for the quarter ended June 2024, compared to a profit of Rs 146 million a year ago. Net sales rose 22.0% to Rs 1,702 million during the period as against Rs 1,396 million in April-June 2023.

For the year ended March 2024, KRSNAA DIAGNOSTICS reported 8.5% decrease in net profit to Rs 568 million compared to net profit of Rs 621 million during FY23. Revenue of the company grew 27.2% to Rs 6,196 million during FY24.

The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 44.4.


Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 6%; BSE HEALTHCARE Index Up 1.9%". Click here!